Gurbuxani S - Search Results

1

LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms.

Marinaccio C, Suraneni P, Celik H, Volk A, Wen QJ, Ling T, Bulic M, Lasho T, Koche RP, Famulare CA, Farnoud N, Stein B, Schieber M, Gurbuxani S, Root DE, Younger ST, Hoffman R, Gangat N, Ntziachristos P, Chandel NS, Levine RL, Rampal RK, Challen GA, Tefferi A, Crispino JD. Marinaccio C, et al. Among authors: gurbuxani s. Cancer Discov. 2021 Jun;11(6):1398-1410. doi: 10.1158/2159-8290.CD-20-1353. Epub 2021 Feb 12. Cancer Discov. 2021. PMID: 33579786 Free PMC article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 38193718

3

Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults.

Johnston H, Youshanlouei HR, Osei C, Patel AA, DuVall A, Wang P, Wanjari P, Segal J, Venkataraman G, Cheng JX, Gurbuxani S, Lager A, Fitzpatrick C, Thirman M, Nawas M, Liu H, Drazer M, Odenike O, Larson R, Stock W, Saygin C. Johnston H, et al. Among authors: gurbuxani s. Blood Adv. 2024 Jan 9;8(1):164-171. doi: 10.1182/bloodadvances.2023011862. Blood Adv. 2024. PMID: 38039510 Free PMC article.

4

Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.

Mundschau G, Gurbuxani S, Gamis AS, Greene ME, Arceci RJ, Crispino JD. Mundschau G, et al. Among authors: gurbuxani s. Blood. 2003 Jun 1;101(11):4298-300. doi: 10.1182/blood-2002-12-3904. Epub 2003 Jan 30. Blood. 2003. PMID: 12560215 Free article.

5

Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.

Gurbuxani S, Vyas P, Crispino JD. Gurbuxani S, et al. Blood. 2004 Jan 15;103(2):399-406. doi: 10.1182/blood-2003-05-1556. Epub 2003 Sep 25. Blood. 2004. PMID: 14512321 Free article. Review.

6

Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.

Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD. Greene ME, et al. Among authors: gurbuxani s. Blood Cells Mol Dis. 2003 Nov-Dec;31(3):351-6. doi: 10.1016/j.bcmd.2003.08.001. Blood Cells Mol Dis. 2003. PMID: 14636651

7

Differential requirements for survivin in hematopoietic cell development.

Gurbuxani S, Xu Y, Keerthivasan G, Wickrema A, Crispino JD. Gurbuxani S, et al. Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11480-5. doi: 10.1073/pnas.0500303102. Epub 2005 Jul 29. Proc Natl Acad Sci U S A. 2005. PMID: 16055565 Free PMC article.

8

Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells.

Leung CG, Xu Y, Mularski B, Liu H, Gurbuxani S, Crispino JD. Leung CG, et al. Among authors: gurbuxani s. J Exp Med. 2007 Jul 9;204(7):1603-11. doi: 10.1084/jem.20062395. Epub 2007 Jun 18. J Exp Med. 2007. PMID: 17576776 Free PMC article.

9

Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.

Kirsammer G, Jilani S, Liu H, Davis E, Gurbuxani S, Le Beau MM, Crispino JD. Kirsammer G, et al. Among authors: gurbuxani s. Blood. 2008 Jan 15;111(2):767-75. doi: 10.1182/blood-2007-04-085670. Epub 2007 Sep 27. Blood. 2008. PMID: 17901249 Free PMC article.

10

FOG-1-mediated recruitment of NuRD is required for cell lineage re-enforcement during haematopoiesis.

Gao Z, Huang Z, Olivey HE, Gurbuxani S, Crispino JD, Svensson EC. Gao Z, et al. Among authors: gurbuxani s. EMBO J. 2010 Jan 20;29(2):457-68. doi: 10.1038/emboj.2009.368. Epub 2009 Dec 10. EMBO J. 2010. PMID: 20010697 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters